120
Participants
Start Date
November 4, 2022
Primary Completion Date
June 23, 2025
Study Completion Date
December 31, 2029
Xeltis Hemodialysis Access (aXess) graft
The aXess graft is a sterile, regenerative biodegradable polymer-based vascular graft, consisting of a tubular structure with a 6mm inner diameter. It is comprised of a highly porous polymer matrix and an embedded electropolished nitinol reinforcement layer (Strain Relief System). The aXess graft is able to support both straight and loop configurations and may be implanted in the upper arm and forearm.
AZ Sint Jan Brugge, Bruges
ZOL Genk, Genk
UZ Ghent, Ghent
Universitätsklinikum Köln, Cologne
LAIKO General Hospital of Athens, Athens
University General Hospital of Patras, Pátrai
Ospedali Riuniti Torrette di Ancona, Ancona
Policlinico di Bari, Bari
Policlinico di Sant'Orsola, Bologna
Università degli studi di Padova / Azienda ospedaliera di Padova, Padua
Universita degli studi dell'Insubria, Varese
Pauls Stradins Clinical University Hospital, Riga
Private hospital MedPolonia Poznan, Poznan
The Lower Silesia Center of Heart Diseases MEDINET, Wroclaw
Santa Maria Hospital, Lisbon
Grupo de Estudos Vasculares, Porto
DaVita Sacavém, Sacavém
Bellvitge University Hospital, Barcelona
Hospital Clínic de Barcelona, Barcelona
Hospital Universitario de la Ribera, Valencia
University Hospitals Birmingham - QE, Birmingham
Queen Elizabeth University Hospital, Glasgow
Lead Sponsor
Xeltis
INDUSTRY